Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Review

Published on 12 Nov 2024

Current insights on m6A RNA modification in acute leukemia: therapeutic targets and future prospects

in Pharmacology of Anti-Cancer Drugs

Parminder Kaur
Pankaj Sharma
Prateek Bhatia
Minu Singh

Frontiers in Oncology

doi 10.3389/fonc.2024.1445794

1,028 views

Original Research

Published on 08 Nov 2024

Mechanism of luteolin against non-small-cell lung cancer: a study based on network pharmacology, molecular docking, molecular dynamics simulation, and in vitro experiments

in Pharmacology of Anti-Cancer Drugs

Jihang Zhang
Changling Li
Wenyi Li
Zhenpeng Shi
Zhenguo Liu
Junyu Zhou
Jing Tang
Zixuan Ren
Yun Qiao
Deshan Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1471109

1,691 views

Correction

Published on 28 Oct 2024

Corrigendum: Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an in vitro and in vivo analysis

in Pharmacology of Anti-Cancer Drugs

Kaushiki Chatterjee
Sumit Mukherjee
Jonathan Vanmanen
Probal Banerjee
Jimmie E. Fata

Frontiers in Oncology

doi 10.3389/fonc.2024.1483410

541 views

Review

Published on 23 Oct 2024

Curcumin as a novel therapeutic candidate for cancer: can this natural compound revolutionize cancer treatment?

in Pharmacology of Anti-Cancer Drugs

Shadiya Fawzul Ameer
Muna Yusuf Mohamed
Qubaa Ahmed Elzubair
Elham Abdullatif M. Sharif
Wisam Nabeel Ibrahim

Frontiers in Oncology

doi 10.3389/fonc.2024.1438040

2,535 views
3 citations

Editorial

Published on 18 Oct 2024

Editorial: Novel drug discovery and design in acute myeloid leukemia: from bench to bedside

in Pharmacology of Anti-Cancer Drugs

Yan-Lai Tang
Zhenhua Chen
Xue-Qun Luo

Frontiers in Oncology

doi 10.3389/fonc.2024.1449636

700 views

Original Research

Published on 18 Oct 2024

Identification and validation of matrix metalloproteinase hub genes as potential biomarkers for Skin Cutaneous Melanoma

in Pharmacology of Anti-Cancer Drugs

Zhongyi Zhang
Mei Zhao
Zubing Zhou
Xiaodan Ren
Yunliang He
Tao Shen
Hongping Zeng

Frontiers in Oncology

doi 10.3389/fonc.2024.1471267

1,338 views
1 citation

Original Research

Published on 10 Oct 2024

Roburic acid inhibits lung cancer metastasis and triggers autophagy as verified by network pharmacology, molecular docking techniques and experiments

in Pharmacology of Anti-Cancer Drugs

Luyao Wang
Huili Chen
Lili Deng
Mengling Hu
Ziqiang Wang
Kai Zhang
Chaoqun Lian
Xiaojing Wang
Jing Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1449143

1,327 views

Editorial

Published on 10 Oct 2024

Editorial: Metals in cancer: from intracellular signaling to therapy

in Pharmacology of Anti-Cancer Drugs

Katia Aquilano
Giuseppe Filomeni
Raffaella Faraonio
Anastasia De Luca

Frontiers in Oncology

doi 10.3389/fonc.2024.1495825

459 views

Review

Published on 09 Oct 2024

From defense to offense: antimicrobial peptides as promising therapeutics for cancer

in Pharmacology of Anti-Cancer Drugs

Hadi Zare-Zardini
Elham Saberian
Andrej Jenča
Razieh Ghanipour-Meybodi
Andrej Jenča
Adriána Petrášová
Janka Jenčová

Frontiers in Oncology

doi 10.3389/fonc.2024.1463088

2,328 views
3 citations

Correction

Published on 30 Sep 2024

Corrigendum: 5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells

in Pharmacology of Anti-Cancer Drugs

Xuehua Zhang
Leilei Zhao
Jinlong Xiao
Yudi Wang
Yunmeng Li
Chaoqun Zhu
He Zhang
Yurui Zhang
Xiao Zhu
Yucui Dong

Frontiers in Oncology

doi 10.3389/fonc.2024.1494738

680 views

Systematic Review

Published on 30 Sep 2024

Administration sequences in single-day chemotherapy regimens for breast cancer: a comprehensive review from a practical perspective

in Pharmacology of Anti-Cancer Drugs

Miaohui Wu
Xiaoyan Huang
Meijun Chen
Yin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1353067

1,716 views

Original Research

Published on 26 Sep 2024

Anoikis in prostate cancer bone metastasis gene signatures and therapeutic implications

in Pharmacology of Anti-Cancer Drugs

Wei Xia
Miao Ye
Bo Jiang
Gang Xu
Guancheng Xiao
Qingming Zeng
Ruohui Huang

Frontiers in Oncology

doi 10.3389/fonc.2024.1446894

1,561 views

Original Research

Published on 17 Sep 2024

Targeting FAK, VEGF, and MTA1 proteins with Terminalia elliptica: a computational approach for anticancer activity

in Pharmacology of Anti-Cancer Drugs

Bhargav Shreevatsa
Shrivatsa Hegde
Prakruthi Narayan
Chandan Dharmashekar
Anisha Jain
Tanveer A. Wani
Samudyata C. Prabhuswamimath
Shiva Prasad Kollur
Chandan Shivamallu

Frontiers in Oncology

doi 10.3389/fonc.2024.1427632

989 views

Original Research

Published on 13 Sep 2024

Association of COX-inhibitors with cancer patients’ survival under chemotherapy and radiotherapy regimens: a real-world data retrospective cohort analysis

in Pharmacology of Anti-Cancer Drugs

Lucas E. Flausino
Isabella N. Ferreira
Wen-Jan Tuan
Maria Del Pilar Estevez-Diz
Roger Chammas

Frontiers in Oncology

doi 10.3389/fonc.2024.1433497

1,437 views

Case Report

Published on 13 Sep 2024

Disitamab vedotin (RC48) long-term regimen in a post-nephroureterectomy patient with metastases: a case report

in Pharmacology of Anti-Cancer Drugs

Weiping Li
Suoshi Jing
Bo Zhao
Wei Jiang
Bin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1419882

1,089 views

Review

Published on 09 Sep 2024

Lonicerae Japonicae Flos with the homology of medicine and food: a review of active ingredients, anticancer mechanisms, pharmacokinetics, quality control, toxicity and applications

in Pharmacology of Anti-Cancer Drugs

Ping Ma
Ling Yuan
Shumin Jia
Ziying Zhou
Duojie Xu
Shicong Huang
Fandi Meng
Zhe Zhang
Yi Nan

Frontiers in Oncology

doi 10.3389/fonc.2024.1446328

1,939 views
1 citation